47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0,1 | 0 | -47,9 |
EBITDA | 0,2 | 0,3 | 0,3 | -2,5 |
Short time liabilities | 2,4 | 3 | 3,7 | 25,9 |
Equity capital | -1,6 | -1,5 | -1,5 | 2,4 |
Operating profit (EBIT) | 0,1 | 0,2 | 0,2 | 12,4 |
Assets | 2,6 | 3,3 | 4,1 | 24,6 |
Net profit (loss) | 0 | 0,1 | 0 | -47,9 |
Cash | 0,1 | 0,5 | 0,6 | 38,4 |
Net income from sale | 13,7 | 16,9 | 19,5 | 15,1 |
Liabilities and provisions for liabilities | 4,2 | 4,8 | 5,6 | 16,1 |
Working assets | 2,3 | 3 | 3,9 | 29,2 |
Depreciation | 0,1 | 0,1 | 0,1 | -22,5 |
% | % | % | p.p. | |
Profitability of capital | -0,1 | -4,6 | -2,5 | 2,1 |
Equity capital to total assets | -59,8 | -46,1 | -36,1 | 10 |
Gross profit margin | 0 | 0,4 | 0,2 | -0,2 |
EBITDA Margin | 1,5 | 1,8 | 1,5 | -0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 64 | 64 | 70 | 6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane